Skip to content

Evaluation of safety and efficacy of a new minimally invasive procedure for weight reduction through gastric fundus ischemia.

Bariatric embolization: Safety and efficacy in weight reduction in patients with body mass index between 30 and 39,9

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-78c25h
Enrollment
Unknown
Registered
2019-06-04
Start date
2018-03-07
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

All the procedures described below were performed in 10 patients, without control group. Gastric fundus embolization procedures were performed under local anesthesia and sedation with intravenous admi
Drug
Device
Procedure/surgery
Radiation
C23.888.144.243
E01.370.600.115.100

Sponsors

Hospital Federal de Bonsucesso
Lead Sponsor
Universidade Federal do Rio de Janeiro
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Ten patients, females, over the age of 18 and under 50 years old; with a diagnosis of obesity grades 1 and 2 and Metabolic Syndrome .

Exclusion criteria

Exclusion criteria: Individuals weighing more than 180 kg; pregnant or wishing to become pregnant within the next six months; with history of gastric surgery, alcoholism or previous drug abuse; with coagulation disorder and presence of advanced heart, lung or liver disease.

Design outcomes

Primary

MeasureTime frame
Clinical safety assessment of bariatric embolization through the absence of severe complications that require rehospitalization after discharge or new surgical interventions to treat it.

Secondary

MeasureTime frame
Evaluate the change in ghrelin levels in pg / ml after the procedure until the sixth month;;Evaluation of weight loss in kg over the six months after the intervention;;Evaluation of the evolution of gastric symptoms before and up to six months after the intervention through the PADYQ questionnaire;;Evaluation of the evolution of binge eating symptoms before and up to six months after intervention through the periodic eating binge scale;;Evaluation of the evolution of the quality of life before and until six months after the intervention through the WHOQOL-BREF questionnaire;;Evaluation of changes in body composition 6 months after the procedure through bioimpedance;;Evaluation of changes in blood pressure levels in mmHg, serum lipids in mg / dL and fasting glucose after the intervention for a period of six months.

Countries

Brazil

Contacts

Public ContactRaphael Levigard

Hospital Federal de Bonsucesso

raphaelbraz@yahoo.com.br+5521992463924

Outcome results

None listed

Source: REBEC (via WHO ICTRP)